Reaction
Blood Iron Increased reporting signals
As of the last recalculation, Blood Iron Increased appears in 1,857 FAERS reports alongside 37 co-occurring drug terms. The strongest observed disproportionality signal is DEFERASIROX (PRR 217.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Deferasirox | 403 | 217.3 | 220.6 |
| Eculizumab | 130 | 28.8 | 28.8 |
| Hydroxyurea | 49 | 26.6 | 26.7 |
| Erythropoietin | 43 | 24.0 | 24.0 |
| Iron Sucrose | 16 | 19.0 | 19.0 |
| Tolterodine Tartrate | 14 | 17.6 | 17.6 |
| Rabeprazole | 31 | 15.9 | 15.9 |
| Ruxolitinib | 83 | 13.5 | 13.6 |
| Epoetin Alfa | 14 | 13.3 | 13.4 |
| Dalteparin Sodium | 11 | 11.7 | 11.7 |
| Doxepin | 10 | 11.1 | 11.1 |
| Ravulizumab | 12 | 10.0 | 10.0 |
| Iron | 52 | 8.9 | 8.9 |
| Doxepin Hydrochloride | 10 | 8.9 | 8.9 |
| Prochlorperazine Maleate | 6 | 7.3 | 7.3 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 15 | 7.2 | 7.2 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 7 | 7.1 | 7.1 |
| Niraparib | 14 | 7.1 | 7.1 |
| Amlodipine Besylate And Valsartan | 7 | 7.1 | 7.1 |
| Voxelotor | 13 | 6.5 | 6.5 |
| Peginterferon Alfa-2A | 31 | 6.5 | 6.5 |
| Ribavirin | 34 | 6.0 | 6.0 |
| Triamcinolone Acetonide | 16 | 5.8 | 5.8 |
| Azacitidine | 15 | 5.7 | 5.7 |
| Darbepoetin Alfa | 25 | 5.3 | 5.3 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 4 | 5.2 | 5.2 |
| Orlistat | 10 | 4.3 | 4.3 |
| Loratadine And Pseudoephedrine Sulfate | 3 | 4.2 | 4.2 |
| Siponimod | 3 | 3.8 | 3.8 |
| Azacitidine For | 6 | 3.7 | 3.7 |
| Eltrombopag Olamine | 7 | 3.4 | 3.4 |
| Diroximel Fumarate | 3 | 2.8 | 2.8 |
| Velpatasvir And Sofosbuvir | 3 | 2.6 | 2.6 |
| Peginterferon Beta-1A | 3 | 2.6 | 2.6 |
| Abaloparatide | 5 | 1.9 | 1.9 |
| Galcanezumab-Gnlm | 4 | 1.4 | 1.4 |
| Cinacalcet Hydrochloride | 5 | 1.2 | 1.2 |